Please select the option that best describes you:

Do you consider post-NAC isolated tumor cells in LNs to be residual disease in TNBC to justify capecitabine?  

Would clinical stage or nodal status affect your decision?



Answer from: Medical Oncologist at Community Practice
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more